Clinical Trial Update: Triheptanoin Treatment Trial for Patients With Adult Polyglucosan Body Disease [Phase 2]

View source ↗

Summary

Phase 2 trial of triheptanoin for Adult Polyglucosan Body Disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glycogen Storage Disease Type Iv
• Polyglucosan Body Disease

Drugs mentioned

• Triheptanoin (triheptanoin)

Snippet

Sponsor: Baylor Research Institute | Conditions: Adult Polyglucosan Body Disease, Glycogen Brancher Enzyme Deficiency | Phase 2 | Status: COMPLETED